Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 7, Issue 4, Pages 347-357

出版商

Elsevier BV

发表日期

2019-03-13

DOI

10.1016/s2213-2600(18)30500-9

联系作者

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now